Related Experiment Videos
Prostate Cancer Awareness Week, 1992: a summary of key findings
E DeAntoni1, E D Crawford, N N Stone
1Division of Urology, University of Colorado Health Sciences Center, Denver.
Summary
Prostate Cancer Awareness Week screens over 500,000 men annually using digital rectal exams (DRE) and prostate-specific antigen (PSA) tests. Despite early detection, adherence to annual screenings remains low.
Area of Science:
- Oncology
- Public Health
- Screening Programs
Background:
- Prostate Cancer Awareness Week, established in 1989, aimed to increase participation in free prostate cancer screenings.
- It has evolved into the largest cancer screening program in the United States, addressing prostate cancer as a significant public health concern.
Purpose of the Study:
- To evaluate the effectiveness of Prostate Cancer Awareness Week in recruiting men for screening.
- To analyze the characteristics of the screened population and the outcomes of early detection methods.
Main Methods:
- Utilized digital rectal examination (DRE) and prostate-specific antigen (PSA) testing for screening.
- Collected data on participant demographics, symptoms, and cancer stage at diagnosis.
Main Results:
- In 1992, over 500,000 men underwent DRE, with more than half also receiving PSA testing.
- Prostate cancers detected showed a more favorable stage distribution (more Stage A, fewer B, C, D) compared to the national average.
- Adherence to annual prostate examinations remained low across participant cohorts, despite screening efforts.
Conclusions:
- The combination of DRE and PSA testing effectively detects prostate cancer at earlier stages.
- Further advancements in PSA testing, including age-specific reference ranges, are being developed.
- Low adherence to annual screenings presents an ongoing challenge for sustained prostate cancer prevention efforts.